Quick Answer: Retatrutide Side Effects
The most common retatrutide side effects are gastrointestinal: nausea (up to 45% at higher doses), diarrhea (33%), and vomiting (23%) based on Phase 2 trial data. Most GI symptoms peak during the first 4–8 weeks and improve as the body adjusts. Serious side effects are rare. Slow titration (increasing dose every 4 weeks) significantly reduces severity.
GLP-1 Side Effects Compared
GLP-1 Side Effects: Retatrutide, Tirzepatide & Semaglutide
GLP-1 medications share a core side effect profile driven by how they slow gastric emptying and reduce appetite. Semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound), and retatrutide all cause nausea, diarrhea, and vomiting at different rates. Retatrutide is Eli Lilly's investigational triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. In Phase 2 trials, it showed up to 24% weight loss, with a higher side effect rate than the approved options. This guide covers the full comparison.
18-25%
Experience Nausea
4-8 wks
Until Symptoms Improve
3
Receptor Targets
Phase 3
Clinical Trials
What Makes Retatrutide Different?
GLP-1
Reduces appetite, slows gastric emptying
GIP
Enhances insulin, improves fat metabolism
Glucagon
Increases energy expenditure, burns fat
Most Common Side Effects
Based on Phase 2 clinical trial data (published in NEJM, 2023), retatrutide's side effects are primarily gastrointestinal, similar to other GLP-1 agonists but with some differences due to the glucagon component.
💡 Note: These rates are from Phase 2 trials with ~300 participants. Phase 3 trials with larger populations may show different rates. The 12mg dose showed the highest efficacy (24% weight loss) and side effects.
Why Retatrutide Side Effects May Differ
The glucagon receptor component adds unique considerations:
Increased Thermogenesis
Glucagon activation increases energy expenditure, which may cause slight increases in heart rate or body temperature in some patients.
Blood Sugar Effects
Glucagon can raise blood sugar, but the GLP-1/GIP components counterbalance this. Net effect is improved glucose control.
Triple Synergy
The three receptors work together for greater weight loss, but the GI effects from GLP-1 remain the dominant side effect source.
Liver Fat Reduction
Glucagon helps mobilize liver fat, potentially reducing fatty liver disease. This is a beneficial "side effect."
When Do Side Effects Improve?
Retatrutide side effects follow a predictable pattern tied to dose escalation:
Week 1-2
Side effects most noticeable during initial dose and escalation.
Week 3-4
Body begins adapting; symptoms start to decrease.
Week 6+
Most patients report significant improvement or resolution.
Dose Escalation
Temporary return of symptoms, usually milder than initial onset.
💡 Pro tip: Retatrutide uses monthly dose escalation in trials. Starting low and increasing slowly over 20+ weeks helps minimize side effects while reaching target doses. See the retatrutide dosage chart for the full escalation timeline.
How to Manage Side Effects
These are the same approaches that work for tirzepatide and semaglutide. For those who continue to struggle despite dietary changes, split dosing (microdosing) is a strategy some users explore to reduce peak drug concentrations and lower GI side effect intensity:
NAUSEA
- Eat smaller, more frequent meals
- Avoid fatty, greasy, or fried foods
- Stop eating when you feel full
- Ginger tea or ginger supplements
- Don't lie down right after eating
DIARRHEA
- Avoid high-fat foods
- Limit artificial sweeteners
- Stay well-hydrated
- Consider probiotics
CONSTIPATION
- Increase fiber intake gradually
- Drink 8+ glasses of water daily
- Consider a fiber supplement
- Regular physical activity
GENERAL TIPS
- Follow the dose escalation schedule
- Track symptoms to identify triggers
- Stay hydrated (especially important)
- Communicate with your provider
Serious Side Effects (From Trial Data)
⚠️ Based on Phase 2 data, watch for these serious effects:
Pancreatitis
- Severe, persistent abdominal pain
- Pain radiating to back
- Nausea/vomiting that won't stop
Gallbladder Issues
- Upper right abdominal pain
- Fever
- Jaundice (yellowing)
Allergic Reactions
- Difficulty breathing
- Severe rash
- Swelling of face/throat
Hypoglycemia Risk
- If using with insulin/sulfonylureas
- Shakiness, sweating, confusion
- Monitor blood sugar closely
How Retatrutide Side Effects Compare to Other GLP-1 Medications
Comparing retatrutide to tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) shows a clear trade-off: higher efficacy comes with moderately higher side effect rates.
Retatrutide
Highest efficacy at 24% weight loss. Glucagon adds thermogenesis and liver fat reduction. Higher GI rates are trade-off.
Tirzepatide
Best efficacy-to-side-effect balance. GIP may reduce nausea vs GLP-1-only. FDA approved, widely available.
Semaglutide
Lowest diarrhea/constipation. Most established safety data. Only option with an oral form (the Ozempic pill for diabetes and Wegovy pill for weight, formerly Rybelsus).
Related guides: Tirzepatide Side Effects · Semaglutide Side Effects
Frequently Asked Questions
Is retatrutide FDA approved?
Not yet. Retatrutide is currently in Phase 3 clinical trials. FDA approval is expected in 2025-2026 if trials are successful. It's available through research or compounding pharmacies.
Are retatrutide side effects worse than tirzepatide?
Phase 2 data suggests slightly higher GI side effect rates at maximum doses, but the difference may not be clinically significant. Both medications have similar side effect profiles overall.
Does the glucagon component cause different side effects?
The glucagon component may cause slight increases in heart rate and affects liver fat metabolism. However, the dominant side effects (nausea, diarrhea) come from the GLP-1 component, similar to other medications.
How long do retatrutide side effects last?
Based on clinical trial data, most patients see improvement within 4-8 weeks. The slow dose escalation (over 20+ weeks to reach maximum dose) helps minimize side effects.
Bottom Line
Here's what the data tells us:
- GI side effects dominate: nausea, diarrhea, vomiting, constipation
- Higher efficacy = slightly higher side effects at maximum doses
- Glucagon adds benefits: liver fat reduction, increased energy expenditure
- Slow escalation helps: 20+ week titration minimizes symptoms
- Still investigational: Phase 3 trials ongoing, FDA decision expected 2025-2026
Sources
- Retatrutide Phase 2 Trial (Jastreboff et al., NEJM 2023)
- TRIUMPH Phase 3 Trial (ClinicalTrials.gov)
- ClinicalTrials.gov
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Retatrutide is an investigational medication not yet approved by the FDA. Always consult with a qualified healthcare provider before starting or changing any medication.